Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Celgene Corporation - Company Profile' returned 5 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Celgene Corporation: PharmaVitae Profile   Datamonitor, Dec 2010, Pages: 88 References Abbreviations Celgene Corporation: PharmaVitae Profile Toxicity Screening 2009   Select Biosciences Ltd, Feb 2009, Pages: 370 - GlaxoSmithKline - Eli-Lilly & Co. - AstraZeneca - Celgene Corporation - Bristol-Myers Squibb Chapter V. Developing Drugs with Safety Signals: Industry Perspectives - University of Maryland - Pfizer - US Acceleron Pharma, Inc. - Product Pipeline Review - H2 2011   Global Markets Direct, Oct 2011, Pages: 65 Anabolic And Anti-Resorptive Properties Oct 16, 2008: Celgene Corporation And Acceleron Pharma Initiates Phase II Study Of ACE-011 May 14, 2007: Acceleron Pharma’s ACE-031 Increases Muscle Mass ProMetic Life Sciences Inc. - Product Pipeline Review - H2 2011   Global Markets Direct, Nov 2011, Pages: 78 and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ProMetic Life Sciences Inc.’s corporate website, SEC filings, investor Simcere Pharmaceutical Group - Product Pipeline Review - H2 2011   Global Markets Direct, Nov 2011, Pages: 87 and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Simcere Pharmaceutical Group’s corporate website, SEC filings, investor Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network